How CBD Works for Dogs and Cats: Dosing and Safety

Essential Data for Cannabinoid Administration

• Receptor Density: Dogs possess a higher concentration of CB1 receptors in the cerebellum compared to humans. This explains their sensitivity to THC and why low-dose CBD may yield noticeable results.
• The Loading Phase: For chronic conditions, immediate relief may not occur. A 7–14 day saturation period is often necessary for cannabinoids to accumulate in fatty tissues and modulate the ECS.
• Pharmacokinetics: Transmucosal administration—applying oil directly to the gums—can be more bioavailable than adding it to food.
• Biphasic Nature: CBD follows a bell-shaped dose-response curve. Low doses may provide stimulation, while high doses can act as a sedative.
• Terpene Synergy: Aromatic compounds like Beta-Caryophyllene act as dietary cannabinoids, targeting CB2 receptors which may assist with localized physical inflammation.

Biological Mechanisms: Receptor Sensitivity and THC Toxicity

Every mammal relies on the ECS to maintain homeostasis, but the canine physiological profile is unique due to the abundance of CB1 receptors in the hindbrain. This density makes dogs particularly susceptible to static ataxia—a clinical loss of coordination—if exposed to THC.

Unlike THC, which binds directly to receptors, CBD acts as an allosteric modulator. It inhibits the enzyme Fatty Acid Amide Hydrolase (FAAH), which is responsible for breaking down anandamide. By slowing the degradation of anandamide, the animal may regulate its own pain and stress responses more effectively.

Targeted Recovery Protocols

Inflammation Modulation

While NSAIDs like carprofen target COX-2 pathways, they can be taxing on the kidneys. CBD may offer a complementary approach by modulating the cytokine response, which could help manage systemic inflammation without the same renal impact.

The Sporting Dog Protocol

Active breeds often struggle with Delayed Onset Muscle Soreness (DOMS). To support the recovery window, administer CBD within 30 to 60 minutes post-exertion. For muscle and tissue repair, prioritize extracts rich in Beta-Caryophyllene, as this terpene interacts with CB2 receptors.

Dosing Logic: The Biphasic Effect and Titration

Because CBD is biphasic, the desired outcome dictates the dosage strategy:

1. Micro-Dosing (0.1 - 0.2 mg/kg): May support mild anxiety or maintain daytime alertness.
2. Therapeutic Dosing (0.5 - 2.0 mg/kg): Often used for chronic mobility issues and pain management.
3. Sedative Dosing (2.0 - 5.0+ mg/kg): May be used for acute scenarios like thunderstorm phobias or sleep induction.

The 14-Day Saturation Strategy

For osteoarthritis or Canine Cognitive Dysfunction (CCD), consistency is the primary driver of potential success.

• Protocol: Start with a baseline dose administered twice daily for 14 days.
• Adjustment: If mobility has not improved by day 14, increase the dose by 25% every 3 days until the desired threshold is reached.

Managing Senior Pet "Sundowning"

Senior pets often experience "sundowning," characterized by nocturnal pacing and restlessness caused by a disrupted circadian rhythm. CBD may assist by reducing glutamate signaling and increasing GABAergic activity.

• Timing: Administer the dose 90 minutes before the intended sleep time.
• Synergy: Pairing CBD with Melatonin may be effective for synchronizing the internal clock in geriatric patients.

Administration Routes and Bioavailability

How the dose is delivered determines the concentration that reaches the bloodstream.

• Transmucosal (Optimal): Applying oil to the gums bypasses the liver’s "first-pass" metabolism, potentially ensuring a faster onset.
• Ingestion (Sub-optimal): Adding CBD to dry kibble often leads to poor absorption because CBD is lipophilic. If using food, ensure the oil is paired with a healthy fat like sardines or MCT oil to improve uptake.

Terpene Profiles in Veterinary Care

Terpenes are bioactive; choose them based on the clinical need:

• Linalool: May support pets with high-cortisol "fight or flight" responses due to its modulation of GABA receptors.
• Myrcene: Increases blood-brain barrier permeability, which may enhance sedative effects.
• Limonene: May be beneficial for senior pets showing lethargy.
• Pinene Caution: Use with care in felines; high concentrations can act as a bronchodilator and may irritate sensitive airways.

Clinical Safety and Drug Interactions

The primary clinical concern regarding CBD is its interaction with the Cytochrome P450 (CYP450) enzyme system in the liver. CBD inhibits these enzymes, which can increase the half-life of other medications.

• Crucial Note: CBD can increase the potency of phenobarbital or slow the clearance of NSAIDs, which may increase the risk of gastric ulcers.

Final Reminder: Always demand a Certificate of Analysis (COA) to confirm the product is 0.0% THC and free from heavy metals or pesticides. Never assume a "pet-safe" label is a substitute for third-party lab verification.

---

Legal Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always seek the advice of a physician regarding a medical condition. Efficacy has not been confirmed by FDA-approved research. Check your local laws regarding cannabis and terpene use.

Sources

1. Gamble LJ, Boesch JM, Frye CW, et al. (2018). Pharmacokinetics, safety, and clinical efficacy of cannabidiol treatment in osteoarthritic dogs. Front Vet Sci. 5:165. PubMed

2. Bartner LR, McGrath S, Rao S, Hyatt LK, Wittenburg LA. (2018). Pharmacokinetics of and serum concentrations of cannabidiol following single-dose oral and transmucosal administration of a cannabidiol extract in dogs. Am J Vet Res. 79(10):1029-1038. PubMed

3. Brutlag A, Hommerding H. (2018). Toxicology of marijuana, synthetic cannabinoids, and cannabidiol in dogs and cats. Vet Clin North Am Small Anim Pract. 48(6):1087-1102. PubMed

4. Russo EB. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 163(7):1344-64. PubMed